# Bain Capital Life Sciences' Biotech Investments: 32 Startups in Its Portfolio (2026) > The 32 Biotech startups Bain Capital Life Sciences has backed, by stage: $7.8B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/bain-capital-life-sciences-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 11 - [Nuvalent](https://millionrounds.com/company/nuvalent) - [New Amsterdam Pharma](https://millionrounds.com/company/new-amsterdam-pharma) - [Century Therapeutics](https://millionrounds.com/company/century-therapeutics) - [Nurix Therapeutics](https://millionrounds.com/company/nurix-therapeutics) - [Cabaletta Bio](https://millionrounds.com/company/cabaletta-bio) - [X4 Pharmaceuticals](https://millionrounds.com/company/x4-pharmaceuticals) - [Amylyx Pharmaceuticals](https://millionrounds.com/company/amylyx-pharmaceuticals) - [Replimune Group](https://millionrounds.com/company/replimune-group) - [*2B* 2seventy bio](https://millionrounds.com/company/2seventy-bio) - [*RM* Rapid Micro](https://millionrounds.com/company/rapid-micro) - [Rivus Pharmaceuticals](https://millionrounds.com/company/rivus-pharmaceuticals) ## Series C and later 9 - [Kymera Therapeutics](https://millionrounds.com/company/kymera-therapeutics) - [ADC Therapeutics](https://millionrounds.com/company/adc-therapeutics) - [AdvanCell](https://millionrounds.com/company/advancell) - [Solid Biosciences](https://millionrounds.com/company/solid-biosciences) - [Imperative Care](https://millionrounds.com/company/imperative-care) - [CereVasc](https://millionrounds.com/company/cerevasc) - [Atsena Therapeutics](https://millionrounds.com/company/atsena-therapeutics) - [Jnana Therapeutics](https://millionrounds.com/company/jnana-therapeutics) - [*I* InfalRX](https://millionrounds.com/company/infalrx) ## Series B 8 - [Kailera Therapeutics](https://millionrounds.com/company/kailera-therapeutics) - [SpringWorks Therapeutics](https://millionrounds.com/company/springworks-therapeutics) - [Cardurion Pharmaceuticals](https://millionrounds.com/company/cardurion-pharmaceuticals) - [Upstream Bio](https://millionrounds.com/company/upstream-bio) - [Kyverna Therapeutics](https://millionrounds.com/company/kyverna-therapeutics) - [Alkeus Pharmaceuticals](https://millionrounds.com/company/alkeus-pharmaceuticals) - [Pharvaris](https://millionrounds.com/company/pharvaris) - [Aptinyx](https://millionrounds.com/company/aptinyx) ## Series A 4 - [Merida Biosciences](https://millionrounds.com/company/merida-biosciences) - [*A* AavantiBio](https://millionrounds.com/company/aavantibio) - [Areteia Therapeutics](https://millionrounds.com/company/areteia-therapeutics) - [*E* Eyebiotech](https://millionrounds.com/company/eyebiotech) ## Segment by segment ### Stage not reported 11 startups · $2.5B raised - [**Nuvalent**](https://millionrounds.com/company/nuvalent) Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines. United States $500M - [**New Amsterdam Pharma**](https://millionrounds.com/company/new-amsterdam-pharma) New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases. Netherlands $453M - [**Century Therapeutics**](https://millionrounds.com/company/century-therapeutics) Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies. United States $385M - [**Nurix Therapeutics**](https://millionrounds.com/company/nurix-therapeutics) Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs. United States $250M - [**Cabaletta Bio**](https://millionrounds.com/company/cabaletta-bio) Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases. United States $200M - [**X4 Pharmaceuticals**](https://millionrounds.com/company/x4-pharmaceuticals) X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment. United States $193M - [**Amylyx Pharmaceuticals**](https://millionrounds.com/company/amylyx-pharmaceuticals) Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. United States $175M - [**Replimune Group**](https://millionrounds.com/company/replimune-group) Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer. United States $140M ### Series C and later 9 startups · $2.9B raised - [**Kymera Therapeutics**](https://millionrounds.com/company/kymera-therapeutics) Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. United States $799M - [**ADC Therapeutics**](https://millionrounds.com/company/adc-therapeutics) ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products. Switzerland $646M - [**AdvanCell**](https://millionrounds.com/company/advancell) AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment. Australia $438M - [**Solid Biosciences**](https://millionrounds.com/company/solid-biosciences) Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy. United States $333M - [**Imperative Care**](https://millionrounds.com/company/imperative-care) Imperative Care is a medical technology company based in Campbell, California, focused on developing innovations for patients with United States $196M - [**CereVasc**](https://millionrounds.com/company/cerevasc) CereVasc is a clinical-stage medical device company based in Boston, Massachusetts, focused on developing innovative, minimally in United States $155M - [**Atsena Therapeutics**](https://millionrounds.com/company/atsena-therapeutics) Atsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, focused on developing treatments for United States $150M - [**Jnana Therapeutics**](https://millionrounds.com/company/jnana-therapeutics) Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform. United States $107M ### Series B 8 startups · $2.0B raised - [**Kailera Therapeutics**](https://millionrounds.com/company/kailera-therapeutics) Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management. United States $600M - [**SpringWorks Therapeutics**](https://millionrounds.com/company/springworks-therapeutics) SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer. United States $400M - [**Cardurion Pharmaceuticals**](https://millionrounds.com/company/cardurion-pharmaceuticals) Cardurion Pharmaceuticals is a clinical-stage biotechnology company founded in 2017, focused on developing innovative therapeutics United States $260M - [**Upstream Bio**](https://millionrounds.com/company/upstream-bio) Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. United States $200M - [**Kyverna Therapeutics**](https://millionrounds.com/company/kyverna-therapeutics) Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases. United States $160M - [**Alkeus Pharmaceuticals**](https://millionrounds.com/company/alkeus-pharmaceuticals) Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions. United States $150M - [**Pharvaris**](https://millionrounds.com/company/pharvaris) Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients. Switzerland $132M - [**Aptinyx**](https://millionrounds.com/company/aptinyx) Aptinyx Inc. United States $76M ### Series A 4 startups · $368M raised - [**Merida Biosciences**](https://millionrounds.com/company/merida-biosciences) Merida Biosciences is a biotechnology company based in Cambridge, Massachusetts, focused on developing precision medicines for aut United States $121M - [*A* **AavantiBio**](https://millionrounds.com/company/aavantibio) AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases. - $107M - [**Areteia Therapeutics**](https://millionrounds.com/company/areteia-therapeutics) Areteia Therapeutics, Inc. United States $75M - [*E* **Eyebiotech**](https://millionrounds.com/company/eyebiotech) Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases. United States $65M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Bain Capital Life Sciences as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **Bain Capital Life Sciences portfolio map** 41 startups · $9.3B](https://millionrounds.com/portfolio-maps/bain-capital-life-sciences-portfolio-map)[Co-investors **Who invests with Bain Capital Life Sciences** 36 co-investors](https://millionrounds.com/portfolio-maps/bain-capital-life-sciences-co-investors)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio)[Sector portfolio **Pioneer Fund's AI portfolio** 171 startups · $2.8B](https://millionrounds.com/portfolio-maps/pioneer-fund-2-ai-portfolio)[Sector portfolio **Gaingels' AI portfolio** 146 startups · $14B](https://millionrounds.com/portfolio-maps/gaingels-ai-portfolio) ## Raising from investors like Bain Capital Life Sciences? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)